Literature DB >> 18937888

Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma.

M M Zulkifli1, R Ibrahim, A M Ali, I Aini, H Jaafar, S S Hilda, N B Alitheen, J M Abdullah.   

Abstract

INTRODUCTION: Newcastle disease virus (NDV) is a virus of paramyxovirus family and lately has been studied for the treatment of cancer in human. In this study, we successfully determined the oncolysis potential of NDV vaccine, V4UPM tested on the human glioblastoma multiform cell line (DBTRG.05MG) and human glioblastoma astrocytoma cell line (U-87MG) in vitro and in vivo. The V4UPM strain is a modified V4 strain developed as thermostable feed pellet vaccine for poultry.
OBJECTIVE: The objectives of this study were mainly to evaluate the cytolytic effect and subsequently determine the brain tumor regression potential induced by this strain in athymic mice model. METHODOLOGY AND
RESULTS: V4UPM, the avirulent strain of NDV, was propagate and screened for the cytolytic activity towards DBTRG.05MG and U-87MG using MTT assay. The inhibition concentration 50% (IC(50)) values by monolayer method measured at hour 72 were 23 and 9 HAU/ml, respectively. Further study was carried out to observe an apoptosis of the infected cells by AO/PI staining and revealed the apoptosis features of the treated cells. Subcutaneous human brain tumors grown on the nude mice were treated by V4UPM at IC(80) and complete regression of U-87MG-bearing tumor mice was observed. TUNEL assay analysis of treated tumor tissues from treated mice showed an occurrence of apoptosis.
CONCLUSION: From this study, NDV strain V4UPM inhibits the proliferation of experimental human gliomas in tissue culture and IC(80) at 520 HAU V4UPM gives potent effect to induced tumor regression and apoptosis in malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937888     DOI: 10.1179/174313208X325218

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  23 in total

Review 1.  Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.

Authors:  Guido Wollmann; Koray Ozduman; Anthony N van den Pol
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

Review 2.  Oncolytic viral therapy of malignant glioma.

Authors:  Jacqueline Nuss Parker; David F Bauer; James J Cody; James M Markert
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 3.  Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy.

Authors:  Drew A Spencer; Jacob S Young; Deepak Kanojia; Julius W Kim; Sean P Polster; Jason P Murphy; Maciej S Lesniak
Journal:  Ther Deliv       Date:  2015

Review 4.  The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.

Authors:  Russell Maxwell; Andrew S Luksik; Tomas Garzon-Muvdi; Michael Lim
Journal:  Curr Neurol Neurosci Rep       Date:  2017-06       Impact factor: 5.081

Review 5.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

6.  Recent advances of oncolytic virus in cancer therapy.

Authors:  Moumita Mondal; Jingao Guo; Ping He; Dongming Zhou
Journal:  Hum Vaccin Immunother       Date:  2020-02-20       Impact factor: 3.452

7.  EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA.

Authors:  Dipongkor Saha; Seemin S Ahmed; Samuel D Rabkin
Journal:  Drugs Future       Date:  2015       Impact factor: 0.148

8.  Current status of gene therapy for brain tumors.

Authors:  Andrea M Murphy; Samuel D Rabkin
Journal:  Transl Res       Date:  2012-12-11       Impact factor: 7.012

9.  Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.

Authors:  Zhigang Liu; Xiumei Zhao; Hua Mao; Patricia A Baxter; Yulun Huang; Litian Yu; Lalita Wadhwa; Jack M Su; Adekunle Adesina; Lazlo Perlaky; Mary Hurwitz; Neeraja Idamakanti; Seshidhar Reddy Police; Paul L Hallenbeck; Richard L Hurwitz; Ching C Lau; Murali Chintagumpala; Susan M Blaney; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300

10.  Viability reduction and Rac1 gene downregulation of heterogeneous ex-vivo glioma acute slice infected by the oncolytic Newcastle disease virus strain V4UPM.

Authors:  Zulkifli Mustafa; Hilda Shazana Shamsuddin; Aini Ideris; Rohaya Ibrahim; Hasnan Jaafar; Abdul Manaf Ali; Jafri Malin Abdullah
Journal:  Biomed Res Int       Date:  2013-03-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.